查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1873980

腺苷三磷酸（ATP）拭子檢測市場

Adenosine Triphosphate (ATP) Swab Test Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024年腺苷三磷酸（ATP）拭子檢測市場價值約2.9862億美元，預計到2031年將達到5.3516億美元。此成長意味著2031年至2031年間的年複合成長率（CAGR）為9.2%。 ATP拭子檢測市場的一個重要趨勢是基於腺苷酸（A3）濃度的現代無菌監測系統的發展。

腺苷三磷酸（ATP）拭子檢測市場分析

醫療相關感染（HAI）發生率的不斷上升是推動ATP拭子檢測需求成長的主要因素。例如，世界衛生組織（WHO）於2022年5月發布了首份全球感染預防與控制報告，指出在急性護理醫院的每100名患者中，高收入國家有7名患者，中低收入國家有15名患者在住院期間面臨感染至少一種HAI的風險。平均而言，每10名HAI患者中就有1名會因此死亡。 HAI的高發生率預計將積極促進ATP拭子檢測的普及，從而推動ATP拭子檢測市場的成長。

腺苷三磷酸（ATP）拭子檢測市場概覽

ATP拭子檢測市場的擴張主要受多種關鍵因素驅動，包括醫院感染（HAI）發生率的上升和人們對食品安全的日益重視。然而，ATP拭子檢測的限制也對市場成長構成挑戰。全球ATP拭子檢測市場按地區分類為北美、歐洲、亞太、中東和非洲以及南美和中美洲。在北美，美國是ATP拭子檢測的最大市場，這主要得益於主要市場參與者的存在以及醫院感染的日益普遍。此外，持續的產品創新預計將進一步促進北美ATP拭子檢測市場的成長。

預計亞太地區將成為ATP拭子檢測市場成長最快的地區。醫療保健和食品飲料行業的快速擴張，以及亞太地區領先市場參與者在衛生監測系統方面不斷加大投資和創新，有望推動市場成長。

戰略洞察

腺苷三磷酸（ATP）拭子檢測市場的促進因素和機會

食源性疾病和污染事件的增加有利於市場成長

世界衛生組織報告稱，每年全球因不安全食品導致6億例食源性疾病和42萬人死亡，其中5歲以下兒童佔死亡人數的30%。此外，世衛組織估計，不安全食品的消費每年導致3,300萬健康壽命的損失，而這很可能是個低估的數字。受污染的食物可引發200多種疾病，顯著加重了全球疾病負擔和死亡率。 ATP檢測在食品生產環境中至關重要，因為清潔不當會促進微生物滋生。食品也可能為細菌、黴菌和酵母提供營養，導致它們大量繁殖。因此，ATP檢測可作為早期預警系統，確保食品環境的衛生。食源性疾病的高發生率增加了人們對食品安全的需求，預計這將推動ATP拭子檢測市場在預測期內成長。

日益重視病人安全與照護－ATP拭子檢測市場的客製化機會

醫院感染是導致住院病患死亡和發病的主要原因之一，對全球病患和醫療系統帶來額外的經濟和情緒負擔。因此，各國政府和醫療衛生機構正將預防醫院感染的安全計畫列為優先事項。例如，2024年，第七十二屆世界衛生大會通過了「全球病人安全行動」的WHA72.6號決議，該決議要求制定全球病人安全行動計畫。 《2021-2030年全球病人安全行動計畫》為各利害關係人進行病人安全合作提供了全面的架構。預計此類政策的實施將為ATP拭子檢測市場創造可觀的成長機會。

腺苷三磷酸（ATP）拭子檢測市場區隔分析

ATP拭子檢測市場分析的關鍵細分市場包括類型和應用。

  • 按類型分類，ATP拭子檢測市場分為遊離ATP檢測和微生物ATP檢測，其中遊離ATP檢測部分在2023年佔據更大的市場佔有率。
  • 從應用角度來看，市場分為製藥和生物技術公司、食品和飲料、醫院和診斷實驗室以及學術和研究機構，其中製藥和生物技術公司在 2023 年將引領市場。

腺苷三磷酸（ATP）拭子檢測的地理市場佔有率分析

ATP拭子檢測市場報告的地理分析分為五個區域：北美、亞太、歐洲、中東和非洲以及南美/南美和中美洲。

北美一直是ATP拭子檢測市場的主導地區。根據美國疾病管制與預防中心（CDC）估計，美國醫院每年約有170萬例醫院感染病例和9.9萬例相關死亡病例。醫院感染負擔的加重預計將推動北美對ATP拭子檢測的需求。同樣，食源性疾病和污染發生率的上升也促進了市場成長。預計未來幾年，亞太地區的複合年成長率將最高。

腺苷三磷酸（ATP）拭子檢測市場報告範圍

腺苷三磷酸（ATP）拭子檢測市場的最新發展

ATP拭子檢測市場評估是基於從一手和二手研究中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。 ATP拭子檢測市場的主要發展包括：

  • Ecolab食品飲料北美公司與食品安全和環境快速診斷檢測技術領域的領導企業Hygiena, LLC達成合作。此次合作將為食品飲料產業提供一套全新的衛生監測方案，以加強其食品安全措施。 （資料來源：Hygiena LLC，2020年新聞稿，腺苷三磷酸（ATP）拭子檢測）

腺苷三磷酸（ATP）拭子檢測市場報告的覆蓋範圍和交付成果

題為《三磷酸腺苷（ATP）拭子檢測市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 涵蓋範圍內所有關鍵細分市場的全球、區域和國家層面的市場規模和預測
  • 市場動態，例如促進因素、限制因素和關鍵機會
  • 未來主要趨勢
  • 詳細的PEST/波特五力模型與SWOT分析
  • 全球及區域市場分析，重點在於關鍵趨勢、主要參與者、法規及最新發展。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展動態
  • 深入的公司概況

目錄

第1章：引言

第2章：三磷酸腺苷（ATP）拭子檢測市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：全球三磷酸腺苷（ATP）拭子檢測市場及市場概況

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲 PEST 分析
    • 亞太地區及PEST分析
    • 中東和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 專家意見

第5章：三磷酸腺苷（ATP）拭子檢測市場及主要市場動態

  • 市場促進因素
    • 醫療相關感染（HAI）盛行率上升
    • 日益重視食品安全
  • 市場約束
    • ATP拭子檢測的局限性
  • 市場機遇
    • 增加對病人安全和照護的投入
  • 未來趨勢
    • 基於腺苷酸（A3）濃度的現代無菌監測系統的開發
  • 影響分析

第6章：三磷酸腺苷（ATP）拭子檢測市場及全球分析

  • 全球腺苷三磷酸（ATP）拭子檢測市場收入預測與分析
  • 全球腺苷三磷酸（ATP）拭子檢測市場（依地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：腺苷三磷酸（ATP）拭子檢測市場分析及至2031年的預測與類型

  • 概述
  • 2024 年和 2031 年全球腺苷三磷酸 (ATP) 拭子檢測市場佔有率（按類型分類）(%)
  • 遊離ATP檢測
    • 概述
    • 免費ATP檢測市場收入及至2031年預測
  • 微生物ATP檢測
    • 概述
      • 微生物ATP檢測：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測

第8章：腺苷三磷酸（ATP）拭子檢測市場分析及至2031年的預測與應用

  • 概述
  • 2024 年和 2031 年全球腺苷三磷酸 (ATP) 拭子檢測市場佔有率（按應用領域分類）
  • 製藥和生物技術公司
    • 概述
      • 製藥和生物製藥公司：三磷酸腺苷 (ATP) 拭子檢測市場及收入預測（至 2031 年）
    • 食品和飲料
      • 概述
      • 食品飲料：三磷酸腺苷（ATP）拭子檢測市場及收入預測（至2031年）
    • 醫院和診斷實驗室
      • 概述
      • 醫院和診斷實驗室：三磷酸腺苷 (ATP) 拭子檢測市場及收入預測（至 2031 年）
    • 學術和研究機構
      • 概述
      • 學術及研究機構：三磷酸腺苷（ATP）拭子檢測市場及收入預測（至2031年）

第9章：腺苷三磷酸（ATP）拭子檢測分析及至2031年的預測及地理分析

  • 北美：三磷酸腺苷 (ATP) 拭子檢測市場
    • 概述
    • 北美：三磷酸腺苷（ATP）拭子檢測市場－收入及至2031年的預測
    • 北美：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
    • 北美：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 北美：2024 年和 2031 年按國家分類的三磷酸腺苷 (ATP) 拭子檢測市場（%）
    • 美國：三磷酸腺苷（ATP）拭子檢測及收入預測（至2031年）
      • 美國：三磷酸腺苷（ATP）拭子檢測及收入預測（至2031年）
      • 美國：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 美國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 加拿大：三磷酸腺苷（ATP）拭子檢測及收入預測（至2031年）
      • 加拿大：三磷酸腺苷（ATP）拭子檢測及收入預測（至2031年）
      • 加拿大：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
      • 加拿大：腺苷三磷酸（ATP）拭子檢測市場，依最終用戶和收入分類，並預測至2031年
    • 墨西哥：三磷酸腺苷（ATP）拭子檢測及收入預測（至2031年）
      • 墨西哥：三磷酸腺苷（ATP）拭子檢測及收入預測（至2031年）
      • 墨西哥：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 墨西哥：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
  • 歐洲：三磷酸腺苷（ATP）拭子檢測市場
    • 概述
    • 歐洲：三磷酸腺苷（ATP）拭子檢測市場－收入及至2031年的預測
    • 歐洲：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
    • 歐洲：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 歐洲：2024 年及 2031 年各國腺苷三磷酸 (ATP) 拭子檢測市場規模（%）
    • 德國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 德國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 德國：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 德國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 英國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 英國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 英國：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 英國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 法國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 法國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 法國：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 法國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 西班牙：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 西班牙：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 西班牙：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 西班牙：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 義大利：腺苷三磷酸（ATP）拭子檢測市場、收入及至2031年的預測
      • 義大利：腺苷三磷酸（ATP）拭子檢測市場、收入及至2031年的預測
      • 義大利：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 義大利：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 歐洲其他地區：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 歐洲其他地區：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 歐洲其他地區：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 歐洲其他地區：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
  • 亞太地區：三磷酸腺苷（ATP）拭子檢測市場
    • 概述
    • 亞太地區：三磷酸腺苷（ATP）拭子檢測市場－收入及至2031年的預測
    • 亞太地區：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
    • 亞太地區：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 亞太地區：按國家/地區分類的腺苷三磷酸 (ATP) 拭子檢測市場，2024 年和 2031 年（%）
    • 中國：三磷酸腺苷（ATP）拭子檢測市場及收入預測（至2031年）
      • 中國：三磷酸腺苷（ATP）拭子檢測市場及收入預測（至2031年）
      • 中國：腺苷三磷酸（ATP）拭子檢測市場，依應用、所得分類及至2031年預測
      • 中國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 日本：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 日本：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 日本：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 日本：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 印度：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 印度：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 印度：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 印度：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 韓國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 韓國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 韓國：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 韓國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 澳洲：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 澳洲：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 澳洲：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 澳洲：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 亞太其他地區：三磷酸腺苷（ATP）拭子檢測市場及收入預測（至2031年）
      • 亞太其他地區：三磷酸腺苷（ATP）拭子檢測市場及收入預測（至2031年）
      • 亞太其他地區：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 亞太其他地區：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
  • 中東和非洲：三磷酸腺苷 (ATP) 拭子檢測市場
    • 概述
    • 中東和非洲：三磷酸腺苷（ATP）拭子檢測市場－收入及至2031年的預測
    • 中東和非洲腺苷三磷酸（ATP）拭子檢測市場，按產品和收入分類，並預測至2031年
    • 中東和非洲腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 中東和非洲腺苷三磷酸 (ATP) 拭子檢測市場（按國家/地區分類），2024 年和 2031 年（%）
    • 沙烏地阿拉伯：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 沙烏地阿拉伯：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 沙烏地阿拉伯腺苷三磷酸（ATP）拭子檢測市場，依應用、收入分類及至2031年預測
      • 沙烏地阿拉伯腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 阿拉伯聯合大公國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 阿拉伯聯合大公國：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 阿拉伯聯合大公國：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 阿拉伯聯合大公國：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 南非：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 南非：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 南非腺苷三磷酸（ATP）拭子檢測市場，依應用、所得分類及至2031年預測
      • 南非腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 中東和非洲其他地區：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 中東和非洲其他地區：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 中東和非洲其他地區腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 中東和非洲其他地區：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
  • 南美洲和中美洲：三磷酸腺苷 (ATP) 拭子檢測市場
    • 概述
    • 南美洲和中美洲：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
    • 南美洲和中美洲：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
    • 南美洲和中美洲：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 南美洲和中美洲：按國家分類的腺苷三磷酸 (ATP) 拭子檢測市場，2024 年和 2031 年（%）
    • 巴西：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 巴西：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 巴西：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 巴西：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 阿根廷：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 阿根廷：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 阿根廷：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 阿根廷：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年
    • 南美洲和中美洲其他地區：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 南美洲和中美洲其他地區：三磷酸腺苷（ATP）拭子檢測市場、收入及至2031年的預測
      • 南美洲和中美洲其他地區：腺苷三磷酸（ATP）拭子檢測市場，按應用和收入分類，並預測至2031年
      • 南美洲和中美洲其他地區：腺苷三磷酸（ATP）拭子檢測市場，按類型和收入分類，並預測至2031年

第10章：新冠肺炎疫情對全球三磷酸腺苷（ATP）拭子檢測市場的影響

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 南美洲和中美洲

第11章：三磷酸腺苷（ATP）拭子檢測市場及產業概況

  • 概述
  • 腺苷三磷酸（ATP）拭子檢測市場近期成長策略

第12章：公司簡介

  • 3M
  • Hygiena, LLC
  • Charm Sciences
  • Kikkoman Biochemifa Co
  • Neogen Corporation
  • Ecolab
  • Ruhof Healthcare Corporation
  • LuminUltra Technologies Ltd.
  • MERCK KGaA
  • Promicol
  • PCE Instruments
  • Promega Corporation
  • CHARLES RIVER LABORATORIES, INC

第13章：附錄

簡介目錄
Product Code: TIPRE00014433

The market for Adenosine Triphosphate (ATP) Swab Tests was valued at approximately US$ 298.62 million in 2024 and is projected to reach US$ 535.16 million by 2031. This growth represents a compound annual growth rate (CAGR) of 9.2% through 2031 - 2031. A significant trend in the ATP Swab Test Market is the development of modern sterility monitoring systems based on Adenylate (A3) concentration.

Analysis of the Adenosine Triphosphate (ATP) Swab Test Market

The increasing incidence of Healthcare-Associated Infections (HAIs) is a major factor driving the demand for ATP Swab Tests. For example, the World Health Organization (WHO) released its first global report on Infection Prevention and Control in May 2022, indicating that among every 100 patients in acute-care hospitals, 7 in high-income countries and 15 in low- and middle-income countries are at risk of acquiring at least one HAI during their hospital stay. On average, 1 in 10 patients affected by HAIs will die as a result. This significant prevalence of HAIs is expected to positively influence the adoption of ATP swab tests, thereby propelling the growth of the ATP Swab Test market.

Overview of the Adenosine Triphosphate (ATP) Swab Test Market

The expansion of the ATP Swab Test market is driven by several key factors, including the rising incidence of HAIs and a growing focus on food safety. However, the limitations associated with ATP swab tests pose a challenge to market growth. The global ATP Swab Test market is categorized by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the United States represents the largest market for ATP swab tests, driven by the presence of major market players and the increasing prevalence of HAIs. Additionally, ongoing product innovations are expected to further enhance the growth of the ATP Swab Test market in North America.

The Asia Pacific region is anticipated to experience the fastest growth in the ATP Swab Test market. The rapid expansion of the healthcare and food & beverage sectors, along with increased investments and innovations in hygiene monitoring systems by leading market players in Asia Pacific, is likely to drive market growth.

Strategic Insights

Drivers and Opportunities in the Adenosine Triphosphate (ATP) Swab Test Market

Increasing Incidence of Foodborne Illnesses and Contamination Favoring Market Growth

The WHO reports that unsafe food leads to 600 million cases of foodborne diseases and 420,000 deaths globally each year, with children under five accounting for 30% of these fatalities. Furthermore, WHO estimates that unsafe food consumption results in a loss of 33 million years of healthy life annually, likely an underestimation. Contaminated food can cause over 200 diseases, significantly contributing to global disease burden and mortality. ATP testing is vital in food production settings, as improper cleaning can foster microbial growth. Food can also provide nutrients for bacteria, mold, and yeast, leading to their proliferation. Thus, ATP testing serves as an early warning system to ensure hygienic food environments. The high prevalence of foodborne diseases is increasing the demand for food safety, which is expected to drive the ATP swab test market during the forecast period.

Growing Focus on Patient Safety and Care - Customization Opportunities in the ATP Swab Test Market

HAIs are a leading cause of significant mortality and morbidity among hospital patients, imposing additional financial and emotional burdens on patients and healthcare systems worldwide. Consequently, governments and healthcare authorities are prioritizing safety programs to prevent HAIs. For instance, in 2024, the Seventy-second World Health Assembly adopted resolution WHA72.6 on "Global action on patient safety," which mandates the creation of a global patient safety action plan. The Global Patient Safety Action Plan for 2021-2030 provides a comprehensive framework for stakeholders to collaborate on patient safety initiatives. The implementation of such policies is expected to create attractive growth opportunities for the ATP Swab Test market.

Segmentation Analysis of the Adenosine Triphosphate (ATP) Swab Test Market

Key segments contributing to the ATP Swab Test Market analysis include type and application.

  • By type, the ATP Swab Test market is divided into Free ATP Test and Microbial ATP Test, with the Free ATP Test segment holding a larger market share in 2023.
  • In terms of application, the market is segmented into pharmaceutical and biotechnology companies, food and beverage, hospitals and diagnostic laboratories, and academic and research institutions, with the pharmaceutical and biotechnology companies segment leading the market in 2023.

Geographical Market Share Analysis for Adenosine Triphosphate (ATP) Swab Test

The geographical analysis of the ATP Swab Test Market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has been the leading region in the ATP Swab Test Market. The Centers for Disease Control (CDC) estimates that HAIs account for approximately 1.7 million infections and 99,000 associated deaths annually in American hospitals. The increasing burden of HAIs is expected to drive demand for ATP Swab Tests in North America. Similarly, the rising incidence of foodborne diseases and contamination is also contributing to market growth. The Asia Pacific region is projected to experience the highest CAGR in the coming years.

Scope of the Adenosine Triphosphate (ATP) Swab Test Market Report

Recent Developments in the Adenosine Triphosphate (ATP) Swab Test Market

The ATP Swab Test Market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the ATP Swab Test market include:

  • Ecolab Food and Beverage North America partnered with Hygiena, LLC, a leader in rapid food safety and environmental diagnostic testing technology. This collaboration will provide the food and beverage industry with a new Hygiene Monitoring Program to enhance their Food Safety initiatives. (Source: Adenosine Triphosphate (ATP) Swab Test Hygiena LLC, Press Release, 2020)

Coverage and Deliverables of the Adenosine Triphosphate (ATP) Swab Test Market Report

The report titled "Adenosine Triphosphate (ATP) Swab Test Market Size and Forecast (2021-2031)" offers a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis highlighting key trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments
  • In-depth company profiles

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Adenosine Triphosphate (ATP) Swab Test Market and ByType
    • 1.3.2 Global Adenosine Triphosphate (ATP) Swab Test Market and By Application
    • 1.3.3 Global Adenosine Triphosphate (ATP) Swab Test Market and By Geography

2. Adenosine Triphosphate (ATP) Swab Test Marketand Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Adenosine Triphosphate (ATP) Swab Test Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africaand PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinion

5. Adenosine Triphosphate (ATP) Swab Test Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Healthcare-Associated Infections (HAI)
    • 5.1.2 Increasing Emphasis on Food Safety
  • 5.2 Market Restraint
    • 5.2.1 Limitations of ATP Swab Tests
  • 5.3 Market Opportunity
    • 5.3.1 Growing Spending on Patient Safety and Care
  • 5.4 Future Trend
    • 5.4.1 Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System
  • 5.5 Impact Analysis

6. Adenosine Triphosphate (ATP) Swab Test Market and Global Analysis

  • 6.1 Global Adenosine Triphosphate (ATP) Swab Test Market Revenue Forecast and Analysis
  • 6.2 Global Adenosine Triphosphate (ATP) Swab Test Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2031 andType

  • 7.1 Overview
  • 7.2 Global Adenosine Triphosphate (ATP) Swab Test Market Share by Type2024 and 2031 (%)
  • 7.3 Free ATP Test
    • 7.3.1 Overview
    • 7.3.2 Free ATP Test Market Revenue and Forecast to 2031 (US$ Mn)
  • 7.4 Microbial ATP Test
    • 7.4.1 Overview
      • 7.4.1.1 Microbial ATP Test: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)

8. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2031 and Application

  • 8.1 Overview
  • 8.2 Global Adenosine Triphosphate (ATP) Swab Test Market Share by Application 2024 and 2031 (%)
  • 8.3 Pharmaceutical and Biotechnology Company
    • 8.3.1 Overview
      • 8.3.1.1 Pharmaceutical and biopharmaceutical companies: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)
    • 8.3.2 Food and Beverage
      • 8.3.2.1 Overview
      • 8.3.2.2 Food and Beverage: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)
    • 8.3.3 Hospitals and Diagnostics Laboratories
      • 8.3.3.1 Overview
      • 8.3.3.2 Hospitals and Diagnostics Laboratories: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)
    • 8.3.4 Academic and Research Institutions
      • 8.3.4.1 Overview
      • 8.3.4.2 Academic and Research Institutions: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)

9. Adenosine Triphosphate (ATP) Swab Test Analysis and Forecasts To 2031 and Geographical Analysis

  • 9.1 North America: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.1.1 Overview
    • 9.1.2 North America: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2031 (USD Million)
    • 9.1.3 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 9.1.4 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.1.5 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.1.6 US: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.6.1 US: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.6.2 US: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.1.6.3 US: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.1.7 Canada: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.7.1 Canada: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.7.2 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
      • 9.1.7.3 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 9.1.8 Mexico: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.8.1 Mexico: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.8.2 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.1.8.3 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
  • 9.2 Europe: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2031 (USD Million)
    • 9.2.3 Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
    • 9.2.4 Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.5 Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.2.6 Germany: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.6.1 Germany: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.6.2 Germany: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.6.3 Germany: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.7 UK: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.7.1 UK: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.7.2 UK: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.7.3 UK: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.8 France: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.8.1 France: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.8.2 France: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.8.3 France: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.9 Spain: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.9.1 Spain: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.9.2 Spain: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.9.3 Spain: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.10 Italy: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.10.1 Italy: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.10.2 Italy: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.10.3 Italy: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.11 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.11.1 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.11.2 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.11.3 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
  • 9.3 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2031 (USD Million)
    • 9.3.3 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
    • 9.3.4 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.5 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.3.6 China: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.6.1 China: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.6.2 China: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.6.3 China: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.7 Japan: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.7.1 Japan: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.7.2 Japan: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.7.3 Japan: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.8 India: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.8.1 India: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.8.2 India: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.8.3 India: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.9 South Korea: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.9.1 South Korea: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.9.2 South Korea: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.9.3 South Korea: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.10 Australia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.10.1 Australia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.10.2 Australia: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.10.3 Australia: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.11 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.11.1 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.11.2 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.11.3 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
  • 9.4 Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.4.3 Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Products and Revenue and Forecast to 2031 (USD Million)
    • 9.4.4 Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.5 Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.4.6 Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.6.1 Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.6.2 Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.6.3 Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.7 UAE: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.7.1 UAE: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.7.2 UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.7.3 UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.8 South Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.8.1 South Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.8.2 South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.8.3 South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.9 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.9.1 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.9.2 Rest of Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.9.3 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
  • 9.5 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
    • 9.5.3 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 9.5.4 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.5.5 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.5.6 Brazil: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.6.1 Brazil: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.6.2 Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.5.6.3 Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.5.7 Argentina: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.7.1 Argentina: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.7.2 Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.5.7.3 Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.5.8 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.8.1 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.8.2 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.5.8.3 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)

10. Impact Of COVID-19 Pandemic on Global Adenosine Triphosphate (ATP) Swab Test Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Adenosine Triphosphate (ATP) Swab Test Market andIndustry Landscape

  • 11.1 Overview
  • 11.2 Recent Growth Strategies in The Adenosine Triphosphate (ATP) Swab Test Market

12. Company Profiles

  • 12.1 3M
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Hygiena, LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Charm Sciences
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Kikkoman Biochemifa Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Neogen Corporation
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Ecolab
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Ruhof Healthcare Corporation
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 LuminUltra Technologies Ltd.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MERCK KGaA
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Promicol
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 PCE Instruments
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Promega Corporation
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 CHARLES RIVER LABORATORIES, INC
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms, Adenosine Triphosphate (ATP) Swab Test Market